Christina E. Kostara

Stavrou Niarchou Avenue
Ioannina, ESYE21 45500, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Hemorheological Alterations as a Driver of Microangiopathy in Diabetic Kidney Disease-The Role of Erythrocyte.

Hemorheological Alterations as a Driver of Microangiopathy in Diabetic Kidney Disease-The Role of Erythrocyte.

Journal: International journal of molecular sciences

Published: March 25, 2026

Evaluating a Clinical Decision Support System for Optimizing Total Parenteral Nutrition in Adult Oncology Patients.

Evaluating a Clinical Decision Support System for Optimizing Total Parenteral Nutrition in Adult Oncology Patients.

Journal: Nutrients

Published: January 06, 2026

Metabolomics for Preclinical Detection of Diabetic Kidney Disease: A Comprehensive Review.

Metabolomics for Preclinical Detection of Diabetic Kidney Disease: A Comprehensive Review.

Journal: International journal of molecular sciences

Published: December 23, 2025

Metabolomic profiling in pediatric food allergy: Toward biomarkers for disease characterization and treatment response.

Metabolomic profiling in pediatric food allergy: Toward biomarkers for disease characterization and treatment response.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: December 23, 2025

Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias.

Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias.

Journal: International journal of molecular sciences

Published: November 15, 2025

Lipid Profile and Management of Dyslipidemias in Pregnancy.

Lipid Profile and Management of Dyslipidemias in Pregnancy.

Journal: Journal of cardiovascular development and disease

Published: July 19, 2025

Does statin matter when it comes to Lipoprotein(a) levels?

Does statin matter when it comes to Lipoprotein(a) levels?

Journal: Atherosclerosis

Published: July 07, 2025

Altered HDL Phospholipid and Fatty Acid Profile in MASLD: A Possible Explanation for the Increased CVD Risk.

Altered HDL Phospholipid and Fatty Acid Profile in MASLD: A Possible Explanation for the Increased CVD Risk.

Journal: International journal of molecular sciences

Published: May 08, 2025

The Effect of Low, Moderate, and High Doses of Rosuvastatin on Lipoprotein(a) Levels in Hyperlipidemic Patients with Impaired Fasting Glucose: A Post-Hoc Analysis.

The Effect of Low, Moderate, and High Doses of Rosuvastatin on Lipoprotein(a) Levels in Hyperlipidemic Patients with Impaired Fasting Glucose: A Post-Hoc Analysis.

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: March 04, 2025

Nuclear Magnetic Resonance (NMR)-Based Lipidomics Reveal the Association of Altered Red Blood Cell (RBC) Membrane Lipidome with the Presence and the Severity of Coronary Artery Stenosis.

Nuclear Magnetic Resonance (NMR)-Based Lipidomics Reveal the Association of Altered Red Blood Cell (RBC) Membrane Lipidome with the Presence and the Severity of Coronary Artery Stenosis.

Journal: Molecules (Basel, Switzerland)

Published: September 23, 2024

Effect of dapagliflozin on the serum metabolome in patients with type 2 diabetes mellitus.

Effect of dapagliflozin on the serum metabolome in patients with type 2 diabetes mellitus.

Journal: Journal of diabetes and metabolic disorders

Published: September 02, 2024

The effect of rosuvastatin alone or in combination with fenofibrate or omega-3 fatty acids on lipoprotein(a) levels in patients with mixed hyperlipidemia.

The effect of rosuvastatin alone or in combination with fenofibrate or omega-3 fatty acids on lipoprotein(a) levels in patients with mixed hyperlipidemia.

Journal: Archives of medical sciences. Atherosclerotic diseases

Published: October 17, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026